Tag: Alzheimer’s
Increasing Exercise in Midlife Aids Brain Health
Benefits include lower amyloid burden, while remaining sedentary tied to lower cortical thickness
Risk Factors for Alzheimer Disease Linked to Cognitive Function Before Midlife
Cardiovascular Risk Factors, Aging, and Incidence of Dementia score linked to all cognitive measures in Wave IV (age 26 to 29 years)
Estimated 7.2 Million Americans 65 Years and Older Have Alzheimer Dementia
Overall, 79 percent of Americans would want to know if they had Alzheimer disease before experiencing symptoms or before symptoms interfere
Metabolic Syndrome Linked to Increased Risk for Young-Onset Dementia
Risk for young-onset dementia, Alzheimer disease, and vascular dementia increased in association with MetS
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them
Link Between Global β-Amyloid, Tau Deposition Varies by Sex
Women and those with paternal history of Alzheimer disease have stronger association between Aβ, tau deposition than men or those with maternal history
Low LDL-C Levels Linked to Reduced Risk for Dementia
Statin use linked to reduction in risks for all-cause dementia and Alzheimer disease-related dementia
Social Vulnerability Index Linked to Risk for Alzheimer Disease
Individuals in areas with higher SVI had increased risk for incident AD and faster rate of cognitive decline
Sleep Deficiency Linked to Atrophy of the Inferior Parietal Region of the Brain
Associations seen between less short wave sleep and rapid eye movement sleep with smaller inferior parietal region volumes
Long-Term Gantenerumab May Slow Decline in Dominantly Inherited Alzheimer Disease
Hazard ratio for clinical decline in Clinical Dementia Rating-Sum of Boxes was 0.53 for those treated with gantenerumab the longest
